Loading

BioProcess Insider Focus Presentation: Continuous Biomanufacturing for Increasing Access to Biologics

June 05, 2024
BioProcess Theater Session
In a world where 6 billion people in low to middle income countries lack access to modern biopharmaceutical medicines, Just-Evotec Biologics has developed a continuous manufacturing platform that is reducing the production cost of antibody therapeutics below $50/gram. This innovative technology is incorporated in agile, small-footprint and sustainable J.POD production facilities. The concept has been validated by biosimilar-developer Sandoz who is working in partnership with Just-Evotec Biologics to increase patient access. Our presentation will explain how our unique technologies and business model have the potential to revolutionize the lives of patients irrespective of geography.
Speakers
Jon Gunther, PhD
Vice President of Business Development
Just-Evotec Biologics
Back to Session List

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS